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Abstract
Objectives This study explored group-wise quantitative measures of tract-specific white matter (WM) microstructure and func-
tional default mode network (DMN) connectivity to establish an initial indication of their clinical applicability for early-stage and
follow-up differential diagnosis of Alzheimer’s disease (AD) and behavioural variant frontotemporal dementia (bvFTD).
Methods Eleven AD and 12 bvFTD early-stage patients and 18 controls underwent diffusion tensor imaging and resting state
functional magnetic resonance imaging at 3 T. All AD and 6 bvFTD patients underwent the same protocol at 1-year follow-up.
Functional connectivity measures of DMN and WM tract-specific diffusivity measures were determined for all groups.
Exploratory analyses were performed to compare all measures between the three groups at baseline and between patients at
follow-up. Additionally, the difference between baseline and follow-up diffusivity measures in AD and bvFTD patients was
compared.
Results Functional connectivity of the DMN was not different between groups at baseline and at follow-up. Diffusion abnor-
malities were observed widely in bvFTD and regionally in the hippocampal cingulum in AD. The extent of the differences
between bvFTD and AD was diminished at follow-up, yet abnormalities were still more pronounced in bvFTD. The rate of
change was similar in bvFTD and AD.
Conclusions This study provides a tentative indication that quantitative tract-specific microstructural WM abnormalities, but not
quantitative functional connectivity of the DMN, may aid early-stage and follow-up differential diagnosis of bvFTD and AD.
Specifically, pronounced microstructural changes in anterior WM tracts may characterise bvFTD, whereas microstructural
abnormalities of the hippocampal cingulum may characterise AD.
Key Points
• The clinical applicability of quantitative brain imaging measures for early-stage and follow-up differential diagnosis of
dementia subtypes was explored using a group-wise approach.
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• Quantitative tract-specific microstructural white matter abnormalities, but not quantitative functional connectivity of the
default mode network, may aid early-stage and follow-up differential diagnosis of behavioural variant frontotemporal demen-
tia and Alzheimer’s disease.
• Pronounced microstructural white matter (WM) changes in anterior WM tracts characterise behavioural variant
frontotemporal dementia, whereas microstructural WM abnormalities of the hippocampal cingulum in the absence of other
WM changes characterise Alzheimer’s disease.
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Abbreviations
AD Alzheimer’s disease
ATR Anterior thalamic radiation
AxD Axial diffusivity
BOLD Blood-oxygenation-level dependent
bvFTD Behavioural variant frontotemporal dementia
CGC Cingulate cingulum
CGH Hippocampal cingulum
DMN Default mode network
DTI Diffusion tensor imaging
EPI Echo planar imaging
FA Fractional anisotropy
FDR False discovery rate
FMA Forceps major
FMI Forceps minor
FSL FMRIB Software Library
FSPGR Fast spoiled gradient echo
GM Grey matter
ICV Intracranial volume
IFOF Inferior fronto-occipital fasciculus
ILF Inferior longitudinal fasciculus
IR Inversion recovery
MD Mean diffusivity
MMSE Mini-Mental State Examination
MNI Montreal Neurological Institute
MRI Magnetic resonance imaging
RD Radial diffusivity
ROIs Regions of interest
rs-fMRI Resting state functional magnetic resonance
imaging
SLF Superior longitudinal fasciculus
SPM Statistical Parametric Mapping
T1w T1-weighted
UF Uncinate fasciculus
WM White matter
Introduction
Presenile dementia is a dementia with an onset before the age
of 65 years. The two most common underlying disorders are
Alzheimer ’s disease (AD) and behavioural variant
frontotemporal dementia (bvFTD) [1]. AD is characterised
by an episodic memory disturbance for recently learned
as well as for learning new material, together with at least
one other cognitive disturbance [2]. In contrast, bvFTD is
mainly characterised by behavioural problems such as dis-
inhibition, apathy and loss of empathy [3]. In later stages
of AD and bvFTD, predominance of cognitive impairment
in AD and social/executive impairment in bvFTD [4, 5]
aids differential diagnosis. However, differential diagnosis
can be difficult in early stages of AD and bvFTD, as
symptoms may still be mild and unspecific. BvFTD pa-
tients may present with memory deficits [6, 7] and AD
patients with changes in social behaviour or executive
functioning [5, 7, 8]. Magnetic resonance imaging (MRI)
supports diagnosis, but in early disease stages, conven-
tional (structural) MRI may still appear normal or show
diffuse brain abnormalities unspecific for a dementia sub-
type [9–11]. More advanced MRI techniques, such as dif-
fusion tensor imaging (DTI) and resting state functional
MRI (rs-fMRI), may aid differential diagnosis by detect-
ing more subtle abnormalities that remain unrevealed
using structural MRI [12].
DTI is used to assess white matter (WM) microstructure
of the brain. Previous studies observed more pronounced
microstructural WM abnormalities in bvFTD than in AD
[13, 14] and suggested an anterior-posterior division of
WM abnormalities in bvFTD and AD. Microstructural
WM abnormalities are observed in the anterior brain re-
gions in bvFTD, such as the cingulate cingulum (CGH),
forceps minor (FMI) and uncinate fasciculus (UF), whereas
microstructural WM changes in AD are localised in more
posterior brain regions, such as the forceps major (FMA)
and the hippocampal cingulum (CGH) [15–17]. Rs-fMRI
is used to assess functional connectivity between grey mat-
ter (GM) regions that together form functional brain net-
works. A widely studied network is the default mode net-
work (DMN), known to be affected in both AD and bvFTD
[18]. Previous research has shown DMN differences be-
tween AD and bvFTD, specifically decreased DMN con-
nectivity in AD and increased DMN connectivity in
bvFTD—mostly in the posterior DMN.
Clinical diagnosis may especially benefit from objective
quantitative measures derived from DTI and rs-fMRI in
differentiating subtypes of dementia patients, and patients
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from healthy persons, using group-specific reference
values. In this study, we explored group-wise quantitative
measures of tract-specific WM microstructure and func-
tional connectivity of the DMN in a small patient popula-
tion, to provide an initial indication of their diagnostic
utility for early-stage and over time differentiation of AD
and bvFTD.
Methods
Participants
Patients with a suspected diagnosis of early AD or bvFTD
were recruited soon after their initial visits to the Alzheimer
Centre Rotterdam. Suspected AD or bvFTD diagnosis was
established by a multidisciplinary team of neurologists, neu-
roradiologists, nuclear radiologists, geriatricians and neuro-
psychologists. Diagnostic criteria included patient complaints,
medical history, neurological examination, radiological as-
sessment and full cognitive assessment that were overall sug-
gestive of AD or bvFTD and in line with the established di-
agnostic criteria for AD [2] and bvFTD [3]. Genetic testing
was performed only in case of a positive family history for
dementia. Six bvFTD patients included in this study had a
genetic mutation (5 MAPT, 1 C9ORF72).
Inclusion criteria for this study were an age between 40 and
70 years; suspected diagnosis of early AD [2] or bvFTD [3]; a
Mini-Mental State Examination [19] (MMSE) score of ≥ 20.
Exclusion criteria were contraindications for MRI; an expect-
ed loss to follow-up within one year; other neurological dis-
orders; a different cause of dementia; alternative psychiatric
diagnosis; past or current substance abuse. Diagnosis of either
AD or bvFTDwas confirmed after at least one year follow-up.
Patients underwent the Mini-Mental State Examination
(MMSE) as part of their routine clinical diagnostic work-up.
Healthy controls, matched for age and gender, and without
neurological or psychiatric history, were recruited through ad-
vertisement. Controls underwent neuropsychological testing
and the MMSE as part of this study to rule out cognitive
impairment. The study was approved by the local medical
ethics committee. All participants gave written informed
consent.
Image acquisition
MRI was performed on a 3 T Discovery MR750 system
(GE Healthcare). See Table 1 for acquisition parameters.
Patients underwent identical MRI protocols at baseline
(T0) and at 1-year follow-up (T1). Controls underwent
MRI at T0 only. For anatomical reference, a high-
resolution three-dimensional (3D) inversion recovery (IR)
fast spoiled gradient echo (FSPGR) T1-weighted (T1w)
image was acquired. DTI scans were acquired with spin-
echo echo planar imaging (EPI) and rs-fMRI scans with
gradient echo EPI. For rs-fMRI, participants were
instructed to think of nothing in particular, to focus on a
fixation cross and to remain awake.
Demographical analysis
Between-group differences in age were tested using ANOVA.
Between-group differences in MMSE score were tested using
theWelch-ANOVA and post hoc Games-Howell t tests, due to
unequal variance across groups. Gender was compared across
groups using the chi-square tests. Analyses were done using
IBM SPSS Statistics 21.0 with a significance threshold of
p < 0.05.
GM volume analysis
GM volumes were calculated according to the methods
described in Bron et al (2014) [20]. GM volumes were
obtained from the T1w image using the unified tissue seg-
mentation method of Statistical Parametric Mapping
(SPM8), after which intracranial volume (ICV) was calcu-
lated. Then, GM volume was divided by ICV to correct for
brain size. GM volume (%ICV) was compared for groups
at T0 and at T1 using ANOVA and the post hoc Bonferroni
tests.
Table 1 Acquisition parameters
T1w DTI fMRI
FOV (mm) 240 240 240
TE (ms) 3.06 84.5* 30
TR (ms) 7904 7930 3000
ASSET factor 2 2 2
Flip angle 12° 90° 90°
Acquisition matrix 240 × 240 128 × 128 96 × 96
Slice thickness (mm) 1 2.5 3
Volumes (slices per volume) 1 (176) 28 (59) 200 (44)
Duration (min) 4.41 3.50 10.00
Diffusion-weighted directions n/a 25 n/a
Non-diffusion weighted images n/a 3 n/a
Maximum b value (s/ mm2) n/a 1000 n/a
TI (ms) 450 n/a n/a
T1w, T1-weighted; DTI, diffusion tensor imaging; fMRI, functional mag-
netic resonance imaging; FOV, field of view; TE, echo time; TR, repeti-
tion time; ASSET, array spatial sensitivity encoding technique; TI, inver-
sion time
*TE for DTI was set to minimum. This number represents the average
TE. The range of TE was 81.9–90.8 ms
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Microstructural WM analysis
WM tracts known to be associated with cognitive functions
were selected for tractography: anterior thalamic radiation
(ATR) [21], cingulum (CGH and CGC) [22], FMA [21],
FMI [21, 23], inferior fronto-occipital fasciculus (IFOF)
[24, 25], inferior longitudinal fasciculus (ILF) [24, 25],
superior longitudinal fasciculus (SLF) [26, 27] and UF
[22, 23, 25].
Tracts were generated using automated probabilistic
tractography (AutoPtx) as implemented in FMRIB Software
Library (FSL5) [28]. Median fractional anisotropy (FA), mean
diffusivity (MD), radial diffusivity (RD) and axial diffusivity
(AxD) were established for each tract. The quality of WM
tracts was visually assessed. See supplement $1 for a full
description.
The rate of change (T1-T0) was established for each diffu-
sion measure for each tract. Then, diffusion measures at T0
and T1 and the rates of change were compared between
groups using ANOVA and the post hoc Bonferroni t tests,
unless an age effect was present. Age effects were investigated
using linear regression and, if necessary, taken into account
using ANCOVA. In case of unequal variances across groups,
between-group differences were investigated using theWelch-
ANOVA and post hoc Games-Howell t tests.
Functional connectivity analysis
Using regions of interest (ROIs) of the Hammers atlas
(30 atlases with 83 ROIs; http://brain-development.org/
brain-atlases) [29], GM regions making up the DMN
were selected for functional analysis: bilateral medial
prefrontal cortex, lateral temporal cortex, inferior
parietal lobule, precuneus and posterior cingulate
cortex. ROIs were normalised to Montreal Neurological
Institute (MNI) space.
Functional and structural data were pre-processed using
SPM8 (supplement $2). This was followed by further pre-
processing and analysis using the connectivity toolbox by
Mantini [30, 31]. For each ROI, the average blood oxygena-
tion level–dependent (BOLD) signal was calculated.
Subsequently, the average BOLD signal of each ROI was
correlated with all ROIs separately to assess functional con-
nectivity. A Fisher’s r-to-z transformation was then applied to
allow analysis of between-group functional connectivity dif-
ferences. For both T0 and T1, functional connectivity between
ROIs was established for each group using a random-effect
analysis corrected for multiple comparisons (false discovery
rate (FDR) < 0.001). Between-group differences at T0 and at
T1 were assessed using ANCOVA (p < 0.05) with GM vol-
ume (%ICV) as covariate and as post hoc two-sample t tests
(FDR < 0.05).
Results
Baseline (T0)
Participant characteristics
Baseline data from 11 AD patients, 12 bvFTD patients (9 for
rs-fMRI) and 18 controls were used for the analysis (Table 2;
see supplement $3 for exclusions).
Participants did not differ in age (F(2,38) = 0.498,
p > 0.05), gender (χ2(2) = 2.288, p > 0.05) or education
level (χ2(4) = 3.394, p > 0.05). Education level was un-
known for 2 bvFTD patients, 1 AD patient and 1 con-
trol. MMSE score was different between groups
(F(2,17.1) = 20.213, p < 0.001) and was lower in both
patient groups compared with controls. MMSE score
did not differ between AD and bvFTD.
GM volume
The total GM volume (%ICV) was significantly lower
(F(2,38) = 13.837, p < 0.001) in bvFTD (0.30%ICV, standard
deviation (SD) 0.04) compared with both AD (0.33%ICV, SD
0.03) and controls (0.36%ICV, SD 0.03), but not different
between AD and controls.
WM microstructure
WM tracts were correctly identified in all groups. AD in com-
parison with controls (Table 3) showed higher MD only in the
right CGH. BvFTD in comparison with controls (Table 3;
Fig. 1) showed lower FA and higher MD, RD and AxD in
the bilateral CGH, IFOF, UF and FMI. Higher MD, RD and
AxD in bvFTD compared with controls were additionally ob-
served in the bilateral ATR, ILF and SLF. Further, lower FA
and higher MD and RD in bvFTD compared with controls
were observed in the bilateral CGC. BvFTD in comparison
with AD (Table 3; Fig. 1) showed lower FA and higher MD,
RD and AxD in the bilateral IFOF and UF and FMI. Higher
MD, RD and AxD in bvFTD compared with AD were
Table 2 Demographic characteristics
Group N Mean age Mean MMSE
BvFTD 12 (6 male) 60.3 (7.7) 26.6 (2.8)
BvFTD T1 6 (3 male) 64.0 (3.6) –
AD 11 (8 male) 62.8 (5.0) 25.3 (2.0)
AD T1 11 (8 male) 63.3 (5.0) –
Controls 18 (8 male) 59.8 (6.7) 29.1 (1.0)
BvFTD, behavioural variant frontotemporal dementia; AD, Alzheimer’s
disease; N, sample size. Values given as mean (standard deviation).
MMSE, Mini-Mental State Examination
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Table 3 Mean FA, MD, RD and AxD for each WM tract, for bvFTD, AD and controls at T0. The numbers shown are multiplied by a factor 1000
WM tract L/R FA MD RD AxD
BvFTD AD Controls BvFTD AD Controls BvFTD AD Controls BvFTD AD Controls
ATR L 320.44 328.95 327.82 0.90 0.83 0.81* 0.73 0.68 0.67 1.27 1.18 1.15*
ATR R 315.64 320.27 322.81 0. 93 0.83 0.82 0.76 0.69 0.68 1.31 1.17 1.16*
CGC L 392.62 417.66 438.54 0. 86 0.80 0.81 0.67 0.61 0.60 1.26 1.20 1.23
CGC R 355.58 384.25 403.92 0. 87 0.81 0.81* 0.70 0.63 0.62 1.23 1.17 1.19
CGH L 221.51 256.26 266.75 0. 97 0.88 0.84* 0.85 0.76 0.72* 1.27 1.19 1.13*
CGH R 213.55 244.43 264.69 1.04 0.88 0.84* 0.91 0.76 0.72* 1.34 1.19 1.16*
IFOF L 380.55 403.52 415.33 0.89 0.83 0.82 0.68 0.64 0.62 1.30 1.23 1.23
IFOF R 380.37 402.05 425.34 0.89 0.84 0.82* 0.70 0.64 0.61 1.31 1.24 1.24*
ILF L 373.10 383.60 388.35 0.86 0.83 0.82 0.67 0.64 0.63 1.25 1.21 1.19
ILF R 382.13 389.16 403.75 0.86 0.83 0.82 0.67 0.64 0.62 1.27 1.22 1.20*
SLF L 310.14 327.78 330.49 0.84 0.80 0.79 0.69 0.65 0.65 1.16 1.12 1.11
SLF R 309.32 325.56 330.63 0.84 0.80 0.79 0.70 0.65 0.65 1.17 1.12 1.12
UF L 294.48 329.90 355.41 0.95 0.83 0.82* 0.79 0.68 0.65* 1.29 1.17 1.17*
UF R 282.49 323.75 338.02 0.98 0.85 0.84* 0.83 0.69 0.68* 1.33 1.19 1.19*
FMI n/a 319.98 387.77 421.05 0.96 0.85 0.82* 0.78 0.66 0.62* 1.30 1.23 1.23
FMA n/a 383.12 372.15 399.79 0.83 0.83 0.80 0.64 0.64 0.61 1.30 1.30 1.29
Italicised entries = vs other patient group p < 0.05; Bold entries = vs controls p < 0.05
FA, fractional anisotropy; MD, mean diffusivity; RD, radial diffusivity; AxD, axial diffusivity; WM, white matter; bvFTD, behavioural variant
frontotemporal dementia; AD, Alzheimer’s disease; ATR, anterior thalamic radiation; CGC, cingulum (cingulate); CGH, cingulum (hippocampal);
IFOF, inferior fronto-occipital fasciculus; ILF, inferior longitudinal fasciculus; SLF, superior longitudinal fasciculus; UF, uncinate fasciculus; FMI,
forceps minor; FMA, forceps major; L, left; R, right
*Unequal variance, significance tested with the Welch-ANOVA
Fig. 1 Mean fractional anisotropy (FA) and mean diffusivity (MD) at
baseline and follow-up for individual white matter tracts shown per group
(Alzheimer’s disease (AD), behavioural variant frontotemporal dementia
(bvFTD) and controls). Significant differences (p < 0.05) between groups
indicated by a horizontal line. CGH, cingulum (hippocampal); IFOF,
inferior fronto-occipital fasciculus; ILF, inferior longitudinal fasciculus;
SLF, superior longitudinal fasciculus; UF, uncinate fasciculus; FMI, for-
ceps minor; FMA, forceps major; L, left; R, right
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additionally observed in the bilateral ATR, SLF and right
CGH. Lower FA in bvFTD compared with AD was addition-
ally observed in the left CGH. Further, bvFTD in comparison
with AD showed higher MD and RD in the bilateral CGH,
higher MD and AxD in the left ILF and higher AxD in the
right CGC. For an example of the affected WM tracts, see
Fig. 2 where between-group differences in FA for individual
WM tracts are shown.
Functional connectivity
Significant DMN within-group functional connectivity and
between-group functional connectivity changes were not ob-
served (Fig. 3).
Follow-up (T1)
Participant characteristics
Patients underwent a second MRI approximately 1 year later
at T1 (mean 378 days). Six bvFTD patients did not undergo
MRI at T1 and hence were excluded from T1 data analysis.
Three of these patients had not been consented for a scan at T1
and three patients had progressed too severely. Data from 11
AD patients and 6 bvFTD patients were used for the analysis
(Table 2). Participants did not differ in age (t(15) = 0.311,
p > 0.05) or gender (χ2(1,15) = 0.88, p > 0.05).
GM volume
The total GM volume (%ICV) was different between AD and
bvFTD (t(15) = − 2.266, p < 0.039) and was significantly low-
er in bvFTD (0.27%ICV, SD 0.05) than in AD (0.32%ICV, SD
0.04).
WM microstructure
WM tracts were correctly identified in both groups, except for
in one bvFTD and one AD patient where eight tracts could not
be reconstructed due to low data quality. Data for these tracts
were not used.
BvFTD in comparison with AD (Table 4, Figs. 1 and 2)
showed lower FA and higher MD and RD in the right CGC
and left IFOF. Additionally, higher MD in bvFTD com-
pared with AD was observed in the left CGC and lower
FA in the left UF and FMI. No differences were observed
in AxD.
The rate of change between T1 and T0 (Table 5) of FA
in the cingulum was different between bvFTD and AD.
Specifically, the rate of change of FA in the right CGC
was higher in bvFTD versus a lower change in AD, where-
as the rate of change of FA in the left CGH was lower in
bvFTD versus a higher change in AD. Additionally, the
rate of change of AxD in the right IFOF was also different
between bvFTD and AD; namely, it was lower in bvFTD
versus higher in AD.
Fig. 2 Between-group fractional anisotropy differences (p < 0.05) in
white matter tracts at baseline and follow-up. Light blue, inferior-fronto
occipital fasciculus; yellow, forceps minor; red, cingulate cingulum; dark
blue, hippocampal cingulum; pink, uncinate fasciculus; AD, Alzheimer’s
disease; bvFTD, behavioural variant frontotemporal dementia; L, left
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Functional connectivity
Significant DMN within-group functional connectivity and
between-group functional connectivity changes were not ob-
served (Fig. 4). For this reason, added value and/or sensitivity
of the rate of change analysis was not expected and therefore
not performed.
Discussion
In this study, we explored group-wise quantitative measures of
tract-specific WM microstructure and functional connectivity of
the DMN to provide an initial indication of their diagnostic utility
for early-stage and over time differentiation of AD and bvFTD.
Quantitative tract-specific microstructural WM abnormalities,
but not quantitative functional DMN connectivity, may aid ear-
ly-stage—and possibly over time—differential diagnosis of
bvFTD and AD. Microstructural WM abnormalities were
observed inwidespreadWM tracts in bvFTD,whereas theywere
only seen regionally in AD. Additionally, at follow-up, the dif-
ferences in tract-specific microstructural WM abnormalities be-
tween bvFTD and AD became less pronounced, although they
were still stronger in bvFTD. Despite these diminished differ-
ences, the rate of change was very similar between bvFTD and
AD. It should be noted that this might be an underappreciation of
differences due to bvFTD drop-out at follow-up.
WM microstructure
Baseline
Quantitative microstructural WM abnormalities were seen in
bvFTD and AD in different WM tracts, suggesting a differen-
tial diagnostic role for assessing diffusion values in a clinical
context. Tract-specificWMmicrostructural abnormalitieswere
evident in bvFTD in all WM tracts investigated, but most pro-
nounced in the FMI, CGH, CGC, IFOF and UF. These tracts
Fig. 3 Non-significant default mode network (DMN) connectivity
(p > 0.05; FWEcorrected) at baseline (T0). DMN functional connectivity
for behavioural variant frontotemporal dementia (bvFTD), Alzheimer’s
disease (AD) and controls is shown in row one. Between-group differences
for DMN functional connectivity are shown in row two. Colours represent
the t values of between-region functional connectivity. mPFC, medial
prefrontal cortexmPFC; LTC, lateral temporal cortex; IPL, inferior parietal
lobule; PCC, posterior cingulate cortex; L, left; R, right
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have been associated with cognitive domains characteristically
affected in bvFTD [3]: the FMI with disinhibition and execu-
tive functioning [23, 32], CGH with memory and executive
functioning [33, 34], CGC with cognitive control [35], IFOF
with social cognition and emotional functioning [36, 37] and
the UF with apathy, disinhibition and behavioural dyscontrol
[23, 38, 39]. Unsurprisingly, WM abnormalities were not ob-
served in the FMA, which is a posterior tract associated with
visuospatial functioning [40], a domain generally preserved in
bvFTD [41]. Microstructural WM abnormalities in bvFTD
were evident in comparison with both AD and controls, but
even more pronounced in comparison with the latter. This
smaller difference between bvFTD and AD could indicate that
changes in the WM in AD were already ongoing. AD in com-
parison with controls only showed microstructural abnormali-
ties at baseline, specifically only in the CGH, suggesting the
importance of this structure in AD. Previously, the CGH has
been associated with memory functioning [42, 43], which is
characteristically impaired in AD [2].
Follow-up
At follow-up, microstructural WM abnormalities were still
more pronounced in bvFTD than in AD, but in fewer tracts,
specifically in the left IFOF and UF and right CGC and FMI,
suggesting these may be important for differentiating between
bvFTD and AD at later stages. However, some caution is war-
ranted, as six out of the twelve bvFTD patients did not return
for follow-up. If these patients were more advanced than pa-
tients who participated at follow-up, not including them may
have led to underappreciating WM abnormalities in bvFTD.
CGC involvement in bvFTD is in line with previous liter-
ature showing classification of bvFTD and controls to be best
achieved using FA in the cingulum bundle [44]. The IFOF has
been previously associated with a variety of cognitive do-
mains, such as emotion recognition [37], executive function-
ing [34, 45] and processing speed [46], of which many have
been associated with bvFTD [22, 47, 48]. The UF and FMI are
both known to be important in bvFTD and are associated with
characteristic bvFTD symptoms [23, 32, 38].
The rate of change, in terms of the difference in diffusivity
abnormalities between baseline and follow-up, showed a
faster decline in WM microstructure of the right CGC in
bvFTD and the left CGH and right IFOF in AD. In line with
the observed baseline and follow-up changes and previous
literature [44], this may suggest a differential involvement of
the cingulum, in which the anterior part is more affected in
bvFTD and the posterior part in AD. This is supported by the
Table 4 Mean FA, MD, RD and
AxD for each WM tract, for
bvFTD and AD at T1. The
numbers shown are multiplied by
a factor 1000
WM tract L/R FA MD RD AxD
BvFTD AD BvFTD AD BvFTD AD BvFTD AD
ATR L 341.44 341.57 0.92 0.86 0.74 0.69 1.33 1.24
ATR R 309.17 328.47 0.96 0.87 0. 79 0.71 1.37 1.23
CGC L 392.49 443.31 0.88 0.82 Excluded Excluded 1.28 1.22*
CGC R 346.15 396.49 0.88 0.82 0.71 0.63 1.24 1.19
CGH L 246.78 240.96 0.96 0.90 0. 82 0.78 1.27 1.20
CGH R 220.07 248.85 1.03 0.97 0. 91 0.81* 1.31 1.33
IFOF L 370.40 407.22 0.91 0.85 0.71 0.64 1.32 1.26*
IFOF R 311.60 403.42* 0.88 0.85 0.67 0.65 1.30 1.26
ILF L 357.26 383.46 0.90 0.85 0.71 0.65 1.28 1.23*
ILF R 371.54 384.99 0.87 0.84 0.68 0.66 1.27 1.23
SLF L 310.15 325.04 0.87 0.83 0.72 0.68 1.19 1.17
SLF R 306.60 325.68 0.90 0.84 0.75 0.68 1.26 1.18
UF L 271.33 323.24 1.03 0.90 0.87 0.73 1.35 1.25
UF R 262.51 317.80* 1.16 0.87* 1.00 0.71* 1.53 1.21*
FMI n/a 285.17 378.20 1.20 0.92 1.02 0.71 1.54 1.33
FMA n/a 331.97 376.31 0.92 0.87 0.74 0.66 1.36 1.35
Italicised entries = vs other patient groups p < 0.05
FA, fractional anisotropy;MD, mean diffusivity; RD, radial diffusivity; AxD, axial diffusivity;WM, white matter;
bvFTD, behavioural variant frontotemporal dementia; AD, Alzheimer’s disease; ATR, anterior thalamic radiation;
CGC, cingulum (cingulate); CGH, cingulum (hippocampal); IFOF, inferior fronto-occipital fasciculus; ILF,
inferior longitudinal fasciculus; SLF, superior longitudinal fasciculus; UF, uncinate fasciculus; FMI, forceps
minor; FMA, forceps major; L, left; R, right
*Unequal variance. Significance tested with Welch-ANOVA
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macrostructural frontotemporal (anterior) and temporoparietal
(posterior) involvement in, respectively, bvFTD and AD [40,
49]. The IFOF has been associated with many different
cognitive functions—as described above—but has as yet not
been specifically linked to AD or bvFTD. However, the ob-
served left versus right IFOF involvement in, respectively,
Fig. 4 Non-significant default mode network (DMN) connectivity
(p > 0.05; FWEcorrected) at follow-up (T1). DMN functional connectivity
for behavioural variant frontotemporal dementia (bvFTD) and
Alzheimer’s disease (AD) is shown in columns one and two, respectively.
Between-group comparison for DMN functional connectivity is shown in
column three. Colours represent the t values of between-region functional
connectivity. mPFC, medial prefrontal cortex mPFC; LTC, lateral tempo-
ral cortex; IPL, inferior parietal lobule; PCC, posterior cingulate cortex;
L, left; R, right
Table 5 Mean difference score
(T1 minus T0) of FA, MD, RD
and AxD for each WM tract, for
bvFTD and AD. The numbers
shown are multiplied by a factor
1000
WM tract L/R FA MD RD AxD
BvFTD AD BvFTD AD BvFTD AD BvFTD AD
ATR L 9.80 8.75 0.03 0.03 0.02 0.02 0.05 0.05
ATR R − 9.84 5.81 0.02 0.04 0.03 0.02 0.03 0.06
CGC L − 5.59 20.23 0.01 0.01 0.01 0.0003 0.002 0.01
CGC R − 29.77 10.44 0.02 0.01 0.03 0.001 − 0.002 0.01*
CGH L 13.84 − 19.95 0.03 0.01 0.02 0.01 0.04 − 0.003
CGH R − 5.78 − 1.84 0.03 0.08 0.04 0.05 0.02 0.14
IFOF L − 5.42 − 3.17 0.01 0.01 0.02 0.01 0.02 0.02
IFOF R − 73.01 − 4.87* − 0.003 0.01 − 0.01 0.01 − 0.008 0.02
ILF L − 12.86 − 1.62 0.03 0.01* 0.03 0.01 0.04 0.02*
ILF R − 13.69 − 8.00 0.01 0.01 0.02 0.01 0.01 0.01
SLF L 1.28 − 3.97 0.03 0.03 0.03 0.03 0.04 0.05
SLF R 6.20 − 2.72 0.04 0.05 0.02 0.04 0.07 0.06
UF L − 25.28 − 12.54 0.09 0.07 0.10 0.06 0.08 0.07
UF R − 13.80 − 10.44 0.15 0.02* 0.15 0.02* 0.17 0.02*
FMI n/a − 30.22 − 13.49 0.23 0.07 0.23 0.06 0.24 0.10
FMA n/a − 37.71 − 3.78* 0.08 0.04 0.09 0.03* 0.04 0.06
Italicised entries = vs other patient group p < 0.05
FA, fractional anisotropy;MD, mean diffusivity; RD, radial diffusivity; AxD, axial diffusivity;WM, white matter;
bvFTD, behavioural variant frontotemporal dementia; AD, Alzheimer’s disease; ATR, anterior thalamic radiation;
CGC, cingulum (cingulate); CGH, cingulum (hippocampal); IFOF, inferior fronto-occipital fasciculus; ILF,
inferior longitudinal fasciculus; SLF, superior longitudinal fasciculus; UF, uncinate fasciculus; FMI, forceps
minor; FMA, forceps major; L, left; R, right
*Unequal variance, significance tested with Welch-ANOVA
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bvFTD and AD suggests that a disease-specific link may in
fact be present.
Diffusion metrics sensitive to group differences
Differences between AD and bvFTD were most pronounced
in MD and RD at baseline, and in FA (and to a lesser extent,
MD and RD) at follow-up. First, this suggests that myelin
abnormalities are more pronounced in bvFTD, as RD is
thought to represent myelin damage [50] and AxD axonal loss
[51]. As MD and FA are a combination of these measures, it
may be that their changes observed here are induced by the
changes in RD rather than AxD. Second, this suggests—also
in line with previous literature [16, 44]—that FA,MD and RD
are most sensitive to group changes and are therefore recom-
mended for differentiation between AD and bvFTD.
Functional connectivity
Functional DMN connectivity between AD and bvFTD was
not different using our quantitative method. Previous literature
observed differences in DMN regions using whole-brain in-
dependent component analysis [18, 52–54], such as increased
parietal DMN connectivity in bvFTD and decreased parietal
DMN connectivity in AD. However, in this study, we aimed to
assess a different approach that may be used clinically, i.e. a
quantitative measure of functional connectivity between
DMN regions. The small sample size of this study, and thus
low power, may have left possible group effects undetected.
However, clinical use warrants sensitivity of measures at an
individual patient level; hence, a low sensitivity of quantita-
tive functional DMN connectivity does not seem suitable for
individual diagnostics.
Limitations
This study knows some limitations. First, the small sample size
limits interpretation and generalizability of the results and it
may particularly lead to underestimation of between-group dif-
ferences. However, the findings of this study are in line with
the literature andmay indicate clinical utility of DTI, but not rs-
fMRI, on an individual patient level. Second, sample size was
smaller at follow-up than at baseline which may have induced
an underappreciation of abnormality severity at follow-up and
rate of change differences in the bvFTD patients.
Conclusion
In this explorative group-wise study of quantitative brain MR
measures in dementia, we aimed to provide an indication of
their usefulness for differentiation between AD and bvFTD at
multiple time points. We observed that quantitative tract-
specific microstructural WM abnormalities, but not
quantitative functional connectivity of the DMN, may aid dif-
ferential diagnosis of bvFTD and AD at the early-stage and
possibly over time. Specifically, pronounced microstructural
WM changes in anterior WM tracts may differentiate bvFTD
from AD, and microstructural WM abnormalities of the hip-
pocampal cingulum, in the absence of other microstructural
WM changes, may differentiate AD from bvFTD.
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